Correlation Between Cochlear and Imricor Medical

Can any of the company-specific risk be diversified away by investing in both Cochlear and Imricor Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cochlear and Imricor Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cochlear and Imricor Medical Systems, you can compare the effects of market volatilities on Cochlear and Imricor Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cochlear with a short position of Imricor Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cochlear and Imricor Medical.

Diversification Opportunities for Cochlear and Imricor Medical

-0.36

Correlation Coefficient

Cochlear  Imricor Medical

Very good diversification

The 3 months correlation between Cochlear and Imricor is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Cochlear and Imricor Medical Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imricor Medical Systems and Cochlear is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cochlear are associated (or correlated) with Imricor Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imricor Medical Systems has no effect on the direction of Cochlear i.e., Cochlear and Imricor Medical go up and down completely randomly.

Pair Corralation between Cochlear and Imricor Medical

Assuming the 90 days trading horizon Cochlear is expected to under-perform the Imricor Medical. But the stock apears to be less risky and, when comparing its historical volatility, Cochlear is 2.34 times less risky than Imricor Medical. The stock trades about -0.11 of its potential returns per unit of risk. The Imricor Medical Systems is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  114.00  in Imricor Medical Systems on December 2, 2024 and sell it today you would earn a total of  44.00  from holding Imricor Medical Systems or generate 38.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cochlear  vs.  Imricor Medical Systems

Cochlear

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cochlear has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Imricor Medical Systems

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Imricor Medical Systems are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Imricor Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cochlear and Imricor Medical

The main advantage of trading using opposite Cochlear and Imricor Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cochlear position performs unexpectedly, Imricor Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imricor Medical will offset losses from the drop in Imricor Medical's long position.

The idea behind Cochlear and Imricor Medical Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.